KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Health

MiCo BioMed Creates Kit to Confirm NCoV in an Hour

KoreaTechToday Editor by KoreaTechToday Editor
PUBLISHED: February 5, 2020 UPDATED: February 6, 2020
in Health, Healthcare, MiCo BioMed, South Korea
0
MiCo BioMed logo
MiCo BioMed logo

MiCo BioMed logo

MiCo BioMed Co., Ltd. claimed on Wednesday that it recently developed a highly sensitive rapid molecular diagnostic system to confirm within an hour the 2019 novel coronavirus (2019-nCoV), which was first detected in Wuhan, China.

Mico BioMed, founded in March of 2009, develops and sells medical kits, ultrafast real-time polymerase chain reaction lab chips, ultra-fast lab chip real-time polymerase chain reaction equipment, and other products. The Konex-listed company situated in Seongnam manufactures medical equipment for production in Korea.

CEO Kim Sung-woo, a former Korean American scientist, leads the operations of MiCo BioMed, focusing on immunoassay diagnostics technology, molecular diagnostics, and biological chemistry.

The South Korean health care solutions provider said that the system could immediately detect the 2019-nCoV within one hour. The company will distribute the kit at port quarantine sites and airports besides health care centers.

The biotech company created 30 different varieties of high-risk pathogen diagnostic kits in collaboration with the Korean Centers for Disease Control and Prevention (KCDC). The company used a number of those kits to confirm the presence of bio-terrorism pathogens in vehicles during the 2017 World Cup Games, 2018 Winter Olympics, and 2019 Gwangju Asian Swimming Games.

MiCo BioMed also developed a real-time polymerase chain reaction (PCR) kit to rapidly confirm with high accuracy the 2019-nCoV using the company’s LabChip-powered real-time PCR.

The real-time PCR system is currently awaiting the Emergency Use Approval from the KCDC.

The company said that it expects the systems to be utilized not only at health care facilities but also at harbors and airports as the virus can be rapidly identified within an hour.

In the near future, MiCo BioMed also hopes to apply the kits for other acute infectious diseases such as the Middle East respiratory syndrome (MERS) and the severe acute respiratory syndrome (SARS).

MiCo BioMed recently passed the technical evaluation for relisting on Kosdaq with A grade.

Tags: coronavirushealthcareMiCo BioMedreal-time PCR

Related Posts

South Korea, BlackRock Team Up to Build Hyperscale AI Data Center Hub
MiCo BioMed logo
Data Center

South Korea, BlackRock Team Up to Build Hyperscale AI Data Center Hub

October 1, 2025
Global API Standardization Gets a Push with SK Telecom–Aduna Partnership
MiCo BioMed logo
AI

Global API Standardization Gets a Push with SK Telecom–Aduna Partnership

September 23, 2025
$12B Crypto Wave: How Young Koreans Are Shaping Global Markets
MiCo BioMed logo
Cryptocurrency

$12B Crypto Wave: How Young Koreans Are Shaping Global Markets

September 1, 2025
Caught Between Giants: How U.S. Export Controls Reshape South Korea’s Semiconductor Strategy
MiCo BioMed logo
Samsung

Caught Between Giants: How U.S. Export Controls Reshape South Korea’s Semiconductor Strategy

September 1, 2025
Samsung and SK Hynix Face New U.S. Licensing Rules for Chinese Chip Plants
MiCo BioMed logo
China

Samsung and SK Hynix Face New U.S. Licensing Rules for Chinese Chip Plants

August 31, 2025
South Korea Eyes Global AI Leadership with Record 8.1% Budget Hike
MiCo BioMed logo
AI

South Korea Eyes Global AI Leadership with Record 8.1% Budget Hike

August 30, 2025
No Result
View All Result

Most Popular

  • Ride-Hailing Rivalry: Kakao and Uber Bet on Membership Services in Korea

    0 shares
    Share 0 Tweet 0
  • Kakao Mobility Faces $10.5 Million Fine for Limiting Competitors’ Access to Taxi Platform

    0 shares
    Share 0 Tweet 0
  • Korea’s Navigation Battle Heats Up: Naver and Kakao vs. Google maps

    0 shares
    Share 0 Tweet 0
  • 5 Best Korean to English Translation Apps

    0 shares
    Share 0 Tweet 0
  • Naver Launches 3D Street View for Immersive Navigation Experience

    0 shares
    Share 0 Tweet 0
  • KakaoTalk to Adopt Instagram-Style Feed in Major 2025 Redesign

    0 shares
    Share 0 Tweet 0
  • Naver Maps Launches Guide in English, Chinese, and Japanese to Enhance Travel Experience for Tourists

    0 shares
    Share 0 Tweet 0
  • Top Nine Mobile MMORPG in South Korea for 2020

    0 shares
    Share 0 Tweet 0
  • Naver Unveils Asia’s Largest Data Center, GAK Sejong, for Tech Innovation

    0 shares
    Share 0 Tweet 0
  • South Korea Invests $1.1B to Build National AI GPU Infrastructure

    0 shares
    Share 0 Tweet 0

PRODUCTS

[ads_amazon]

TOPICS

  • Naver
  • Kakao
  • Nexon
  • Netmarble
  • NCsoft
  • Samsung
  • Hyundai

FREE NEWSLETTER

FOLLOW US

  • About Us
  • Cookie policy
  • home
  • homepage
  • mainhome
  • Our Services
  • Privacy Policy
  • Terms of Use

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |

No Result
View All Result
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |